BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 21, 2015
View Archived Issues
First clinical trial results for nivolumab in ovarian cancer
Read More
Interaction of beta7-integrins and MAdCAM-1 shows promise as a therapeutic target for NASH
Read More
Purdue Pharma divulges opioid agonists
Read More
Spectrum Pharmaceuticals reaches agreement with FDA on SPA for of SPI-2012 trial
Read More
Binimetinib improves PFS in phase III melanoma trial compared with dacarbazine
Read More
NeuroRx plans IND application for Cyclurad for the treatment of acute suicidal crisis
Read More
Research Triangle Institute announces APJ agonists
Read More
Beijing Institute of Pharmacology and Toxicology reports mTOR inhibitors
Read More
MAT-2203 granted FDA QIDP and fast track designations for aspergillosis
Read More
Thomas Helledays Stiftelse For Medicinsk Forskning introduces MTH1 inhibitors
Read More
A*STAR presents Wnt pathway inhibitors
Read More
Soligenix's SGX-942 reduces duration of chemoradiotherapy-induced oral mucositis in phase II trial
Read More
ViiV Healthcare to acquire Bristol-Myers Squibb's HIV pipeline
Read More
Cells transduced with the inducible caspase-9 suicide gene well tolerated in children
Read More
Ohara Pharmaceutical submits NDA for crisantaspase in Japan
Read More
Roche patents oxytocin receptor agonists
Read More
Academia Sinica discloses antineoplastic deoxyelephantopin analogues
Read More
Guangzhou Magpie Pharmaceutical reports amantadine nitrate neuroprotectants
Read More
EMA committee recommends approval of lesinurad for hyperuricemia in gout
Read More
Interim phase I results of SGN-LIV1A
Read More
ABP-980 proved similar to FDA-licensed trastuzumab
Read More
Bayer's recombinant factor VIII BAY-81-8973 receives positive CHMP opinion
Read More
EMA CHMP recommends approval of AstraZeneca's osimertinib for NSCLC
Read More
EMA committee backs approval of Brilique 60 mg for patients with history of heart attack
Read More
Development of HCV nucleotide polymerase inhibitor AL-704 terminated
Read More
FDA schedules advisory committee review of eteplirsen NDA
Read More
Portola completes BLA submission for andexanet alfa
Read More
FDA approves Keytruda for first-line treatment of unresectable or metastatic melanoma
Read More
FDA grants breakthrough therapy designation to BI-1482694 for EGFR-mutant NSCLC
Read More